Debra Rodriguez
Adult Health · Pocatello, IDNPI 1275836157
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $477 of the $557 with a category attached, or 85.6%. 18 manufacturers reported payments, led by Actelion Pharmaceuticals US, Inc. at 24.9% of the total.
Across 25 payments — averaging $22.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Actelion Pharmaceuticals US, Inc.$139
- Harmony Biosciences LLC$54
- AstraZeneca$49
- Johnson & Johnson$41
- Jazz Pharmaceuticals Inc.$32
- E.r. Squibb & Sons, L.L.C.$29
- plus $213 from 12 others
What the payments were for
- Food & beverage$47786%
- Education$8014%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Actelion Pharmaceuticals US, Inc. | 2 | $139 |
| Harmony Biosciences LLC | 3 | $54 |
| AstraZeneca | 3 | $49 |
| Johnson & Johnson | 2 | $41 |
| Jazz Pharmaceuticals Inc. | 1 | $32 |
| E.r. Squibb & Sons, L.L.C. | 2 | $29 |
| Pulmonx Corporation | 1 | $23 |
| GSK | 1 | $23 |
| AbbVie | 1 | $20 |
| Verona Pharma, Inc. | 1 | $19 |
| Amgen | 1 | $18 |
| Regeneron Healthcare Solutions, Inc. | 1 | $17 |
| Axsome Therapeutics, Inc. | 1 | $17 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $17 |
| Esperion Therapeutics, Inc. | 1 | $16 |
| Mylan Specialty L.p. | 1 | $16 |
| Viatris Specialty LLC | 1 | $15 |
| Pfizer | 1 | $11 |
How this compares
$557 in reported general payments places this provider in the 55th percentile of 38 adult health providers in Idaho.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 105 | $81,346 |
| Spiriva RespimatTiotropium Bromide | 84 | $46,272 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 30 | $19,035 |
| EliquisApixaban | 16 | $13,870 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 24 | $12,948 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 19 | $10,419 |
| SymbicortBudesonide/Formoterol Fumarate | 24 | $5,637 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 41 | $4,780 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 172 | $4,182 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 21 | $3,343 |
| Ventolin HfaAlbuterol Sulfate | 27 | $1,927 |
| BreynaBudesonide/Formoterol Fumarate | 26 | $786 |
| Montelukast Sodium | 56 | $602 |
| Potassium Chloride | 21 | $359 |
| Levalbuterol Tartrate HfaLevalbuterol Tartrate | 20 | $279 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Anoro Ellipta | $23 | $91,765124 claims |
| AstraZenecaBreztri Aerosphere, Symbicort | $49 | $24,67254 claims |
| PfizerEliquis | $11 | $13,87016 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 38 adult health providers in Idaho.
Other adult health in Pocatello
- Cynthia BarronPocatello$193
- Michelle HicksBoise$40K
- Alisa OrrIdaho Falls$10K
- Tyson HarrisBlackfoot$8K
- Kaitlin HawsBoise$7K
- Jonelle HudsonBoise$6K
- Nicole BartlettTwin Falls$3K
- Leslie HassTwin Falls$2K
- Alla OsipchukCaldwell$2K
- Gregory MoranBoise$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.